News and press releases
Stay up to date with the Association’s news and events.
![](https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/63c809b0acaf27b0a4de4c33_resources-hero_cell1.webp)
![](https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/63c809af6100c642491b1144_resources-hero_cell2.webp)
![](https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/63c809b0c9a071f3e1315c44_resources-hero_cell3.webp)
![](https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/63c809aff7e7c55068ea25b5_resources-hero_cell4.webp)
![](https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/63c809b0c077d95e001f56d8_resources-hero_cell5.webp)
![](https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/63c809b0a95ec247802ff9ad_resources-hero_cell6.webp)
Quick links
Press releases
PPTA statements
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Jan 8, 2021
Yes, you can donate source plasma after getting the COVID vaccine
Recently, news outlets have suggested that people are not allowed to donate source plasma if they have received either of the two experimental COVID-19 vaccines currently available in the U.S. This is incorrect. Current guidance from the U.S. Food and Drug Administration (FDA) recommends that those who have received one of the available vaccines should not donate convalescent plasma. Healthy and eligible people who have received the COVID-19 vaccine are still encouraged to donate regular source plasma for further manufacture into plasma-derived therapies.
All
PPTA statements
Jan 8, 2021
Yes, you can donate source plasma after getting the COVID vaccine
Recently, news outlets have suggested that people are not allowed to donate source plasma if they have received either of the two experimental COVID-19 vaccines currently available in the U.S. This is incorrect. Current guidance from the U.S. Food and Drug Administration (FDA) recommends that those who have received one of the available vaccines should not donate convalescent plasma. Healthy and eligible people who have received the COVID-19 vaccine are still encouraged to donate regular source plasma for further manufacture into plasma-derived therapies.
All
PPTA statements
Dec 11, 2020
PPTA Statement on Alberta’s Passing of the Voluntary Blood Donation Repeal Act
PPTA congratulates the province of Alberta for formally adopting the Voluntary Blood Donations Repeal Act, which repeals the existing ban on compensated plasma donation. This landmark legislation allows the citizens of Alberta to join the millions of source plasma donors worldwide who receive a modest compensation for their commitment to providing the starting material for lifesaving therapies to treat the patients who need them. These therapies are relied upon by people facing rare, serious, and life-threatening conditions and are often the only treatment for this vulnerable population.
All
PPTA statements
Dec 11, 2020
PPTA Statement on Alberta’s Passing of the Voluntary Blood Donation Repeal Act
PPTA congratulates the province of Alberta for formally adopting the Voluntary Blood Donations Repeal Act, which repeals the existing ban on compensated plasma donation. This landmark legislation allows the citizens of Alberta to join the millions of source plasma donors worldwide who receive a modest compensation for their commitment to providing the starting material for lifesaving therapies to treat the patients who need them. These therapies are relied upon by people facing rare, serious, and life-threatening conditions and are often the only treatment for this vulnerable population.
All
PPTA statements
Nov 19, 2020
Inception Impact Assessment Underlines the Need for Timely Action to Decrease the Reliance on Third Countries for Plasma
November 18, 2020 (Brussels, Belgium) The Plasma Protein Therapeutics Association (PPTA) welcomes the European Commission’s publication of the Inception Impact Assessment (IIA) as a necessary step in the ongoing evaluation of the EU legislation on blood, tissues, and cells (BTC).
All
Press releases
Nov 19, 2020
Inception Impact Assessment Underlines the Need for Timely Action to Decrease the Reliance on Third Countries for Plasma
November 18, 2020 (Brussels, Belgium) The Plasma Protein Therapeutics Association (PPTA) welcomes the European Commission’s publication of the Inception Impact Assessment (IIA) as a necessary step in the ongoing evaluation of the EU legislation on blood, tissues, and cells (BTC).
All
Press releases
Nov 4, 2020
PPTA Statement on the Urgent Need for Plasma Donation
COVID-19 continues to present a prolonged, global public health emergency, but PPTA remains steadfastly committed to its mission to promote the availability of — and access to — safe and effective plasma protein therapies for all patients.
All
PPTA statements
Nov 4, 2020
PPTA Statement on the Urgent Need for Plasma Donation
COVID-19 continues to present a prolonged, global public health emergency, but PPTA remains steadfastly committed to its mission to promote the availability of — and access to — safe and effective plasma protein therapies for all patients.
All
PPTA statements
No results found